language
Language
Englishchevron_right
attach_money
Currency
$USDchevron_right
dark_mode
Dark Mode
policy
Privacy Policy
gavel
Terms of Service
SKINSKIN

$0.9127

+0.01
arrow_drop_up1.52%
Market closed·update17 Apr 2026 20:00

$0.9531

+0.04
arrow_drop_up4.43%
Post-market·update17 Apr 2026 23:26
Day's Range
0.911-0.9684
52-week Range
0.757-2.69

Chart

Loading chart...

Performance

Key Stats

Next Earnings Date2026-03-12
Next Earnings TimeAfter Market Close
Volume458.06K
Average Volume 30d688.31K

AI SKIN Summary

Powered by LiveAI
💰
-5.8
Valuation (P/E Ratio)
Trailing twelve months P/E ratio is negative, suggesting unprofitability or growth expectations priced in.
📈
-0.34
EPS Growth (YoY)
EPS has decreased year-over-year, indicating a decline in per-share profitability.
Show More 🔒

AI Scoreboard

Powered by LiveAI
🔒

Overall Analysis

Hold
65

The Beauty Health Company shows mixed signals. Fundamentally, it has a strong market position in the aesthetics industry, but profitability and growth have been inconsistent. Technically, the stock is trading below key moving averages, indicating short-term weakness.

Neutral to Positive

Thematic

70

The Beauty Health Company operates in the growing global beauty and wellness market. Increasing consumer interest in non-invasive aesthetic treatments and self-care provides a positive backdrop, though competition is also rising.

Neutral

Fundamental

68

While the company holds a strong brand in HydraFacial, its recent financial performance shows revenue decline and net losses. Debt levels are significant relative to current cash, and the company has not paid dividends.

Bearish to Neutral

Technical

55

The stock is trading below key longer-term moving averages, indicating a bearish trend. While some short-term indicators suggest potential for a bounce, the overall trend is not yet bullish.

FactorScore
Aesthetic Treatments Market Growth85
Consumer Spending on Beauty & Wellness75
Competitive Landscape50
Innovation & Technology Adoption70
Geographic Expansion70
FactorScore
Valuation60
Profitability20
Growth25
Balance Sheet Health30
Cash Flow65
Earnings Surprise70
FactorScore
Trend Analysis30
Momentum50
Volume Confirmation60
Support & Resistance65
Short-Term Oscillators60

AI Investing Checklist

Powered by LiveAI
thumb_up

Bullish Points (7)

Financial Position chevron_right

Strong Cash Position

The company has a substantial cash and cash equivalents of $370.06M (Q4 2024), providing financial flexibility and stability.

Cash Flow chevron_right

Positive Free Cash Flow

The company generated positive free cash flow of $9.34M in the latest annual period (FY 2024), indicating its ability to cover operational and capital expenditures.

Show More 🔒
thumb_down

Bearish Points (8)

Profitability chevron_right

Negative Net Income and Margins

The company reported a net loss of -$29.1M in 2024 with a net margin of -8.7%, and a net loss of -$100.1M in 2023 with a net margin of -25.2%, indicating current unprofitability.

Valuation chevron_right

Negative P/E Ratio

The Price-to-Earnings (PE) ratio is negative (-5.8 TTM, -6.9 for 2024), which is not uncommon for companies experiencing losses but signals a lack of current earnings profitability.

Show More 🔒

Calendar

August 2025

8

Next Earnings Date

EPS Est.
Revenue Est.

H: $-0.02

A: $-0.02

L: $-0.02

H: 76.70M

A: 74.67M

L: 72.80M

Profile

Employees (FY)769
ISINUS88331L1089
FIGI-

The Beauty Health Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells esthetic technologies and products in the Americas, the Asia-Pacific, Europe, the Middle East, and Africa. The company's flagship product is HydraFacial, which enhances the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. It also offers Syndeo devices, which are delivery systems that are designed to connect providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling and nanoneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive peptide solutions and take home sprays for treating scalp health. In addition, it operates the MyBeautyHealth mobile application for consumers to earn loyalty points and unlock savings, log skin concerns and receive personalized treatment plans, and find and connect with Hydrafacial providers. The Beauty Health Company was founded in 1997 and is headquartered in Long Beach, California.

Seasonals

2025
2024
2023
2022
2021

Price Target

1.66 USD

The 39 analysts offering 1 year price forecasts for SKIN have a max estimate of 2.00 and a min estimate of 1.30.

Debt Level and Coverage

Debt
Free cash flow
Cash & equivalents

Financial Position Analysis

Assets
Liabilities

Ownership

Free Float shares
80.8M (64.14%)
Closely held shares
45.2M (35.86%)
126M
Free Float shares
80.8M (64.14%)
Closely held shares
45.2M (35.86%)

Capital Structure

Market cap
225.53M
Debt
568.16M
Minority interest
0.00
Cash & equivalents
370.06M
Enterprise value
423.62M

Valuation - Summary

Market Cap
226M
Net income
-38.7M(-17.17%)
Revenue
232M(102.81%)
226M
Market Cap
226M
Net income
-38.7M(-17.17%)
Revenue
232M(102.81%)
Price to earning ratio (P/E)-5.80x
Price to sales ratio (P/S)1.00x

Valuation - Ratios

P/E
P/S

Revenue to Profit Conversion

Revenue
334.29M
COGS
152M
Gross Profit
182.3M
OpEx
250.07M
Operating Income
-67.77M
Other & Taxes
-38.68M
Net Income
-29.1M

Balance Sheet

Total assets
Total liabilities
Liabilities to assets %

Income Statement

Revenue
Net Income
Net Margin

Cash Flow

Operating Cash Flow
Investing Cash Flow
Financing Cash Flow
Show More 🔒